MVT-101 nanobubbles represent the next generation of Microvascular Therapeutics’ ultrasound-activated delivery technology.
MVT-101 nanobubble product is for research or investigational use only and is not approved for clinical or diagnostic procedures.
Key Features
Advanced phase-shift nanobubble formulation (~250 nm diameter)
Converts to microbubbles under ultrasound for targeted acoustic activation
Advanced key features provided in COA
Nanobubbles
Product Name: MVT-101 (Phase-Shift Nanobubbles)
Formulation: Sterile lipid nanobubble suspension
Fill Volume: 1.5 mL per vial
Container Type: 2R borosilicate glass vial with sterile rubber stopper and aluminum seal
Appearance: Slightly opalescent, colorless liquidStorage Conditions: Store at -80 °C .
Handling Instructions: Inspect visually for particulate matter or discoloration prior to use.
MVT-101 nanobubble product is for research or investigational use only and is not approved for clinical or diagnostic procedures.

